Clinical Trials

40 enrolled

Lymphoma

NCT05929222 2025-12-24

FIL_GAZEBO

Phase 3 Recruiting

190 enrolled

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT04054167 2025-12-23

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

80 enrolled

Phase 2 Active not recruiting

Lymphoma, Mantle-Cell

NCT00846742 2025-12-08

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

88 enrolled 21 charts

Hodgkin Disease

NCT03907488 2025-12-04

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

994 enrolled 11 charts

Hodgkin Disease

NCT02112916 2025-12-01

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

847 enrolled 19 charts

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02883049 2025-11-26

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

5,949 enrolled 28 charts

Phase 2 Active not recruiting

Burkitt Lymphoma

NCT07247383 2025-11-25

Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma

39 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT03398161 2025-11-03

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

50 enrolled

Mycosis Fungoides

NCT04473937 2025-09-24

Radiation Post-CAR T in Refractory Lymphoma

Phase NA Terminated

3 enrolled 9 charts

Phase NA Active not recruiting

Lymphoma, Hematologic Neoplasms

NCT03681535 2025-09-22

DLBCL

241 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00278408 2025-08-26

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Phase 3 Completed

700 enrolled 21 charts

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00002462 2025-08-05

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

615 enrolled

Hodgkin Disease, Lymphoma

NCT00379041 2025-08-05

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

1,158 enrolled

Hodgkin Disease, Lymphoma

NCT00476190 2025-06-12

ALL Adult Consortium Trial: Adult ALL Trial

Phase 2 Completed

112 enrolled 17 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07000617 2025-06-03

A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma

57 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Extranodal NK-T-Cell

NCT01350258 2025-05-31

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Phase 1/2 Terminated

8 enrolled 8 charts

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01532635 2025-05-04

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Phase 2 Terminated

4 enrolled 8 charts

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00408005 2025-04-20

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Phase 3 Completed

1,895 enrolled 16 charts